27th Dec 2013 07:37
LONDON (Alliance News) - Pharmaceuticals company Shire PLC Friday said it has extended its offer for ViroPharma of the US until the end of January 9, from the end of December 26.
All of the other terms of the offer remain unchanged. Shire said it already has valid acceptances representing 76% of ViroPharma's stock.
By Steve McGrath; [email protected]; @stevemcgrath1
Copyright © 2013 Alliance News Limited. All Rights Reserved.
Related Shares:
Shire